SYNDAX PHARMACEUTICALS INC shareholders Q3 2023

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

SYNDAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ProShare Advisors LLC 13,102$190,2410.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 12,964$188,2370.00%
QUADRANT CAPITAL GROUP LLC 945$13,7220.00%
Bank of New York Mellon Corp 227,504$3,303,3590.00%
Squarepoint Ops LLC 29,120$422,8220.00%
Citadel Advisors 160,700$2,333,3640.00%
Citadel Advisors 318,400$4,623,1680.00%
Citadel Advisors 435,493$6,323,3580.00%
GTS SECURITIES LLC 42,800$621,4560.00%
DekaBank Deutsche Girozentrale 28,300$4310.00%
Nuveen Asset Management, LLC 173,439$2,518,3340.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 63,192$917,5480.00%
JANE STREET GROUP, LLC 150,131$2,179,9020.00%
Swiss National Bank 121,000$1,756,9200.00%
Mirae Asset Global Investments Co., Ltd. 42,192$612,6280.00%
VANGUARD GROUP INC 3,617,302$52,523,2250.00%
PEAK6 Investments LLC 16,000$232,3200.00%
AQR Capital Management 24,572$356,7850.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 116,890$1,697,2430.00%
PRINCIPAL FINANCIAL GROUP INC 43,120$626,1020.00%
External links

This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q3 2023. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.